NCT02478281View on ClinicalTrials.gov

Safety, Tolerability, and Pharmacokinetic Study of Methylene Blue Following a 1 mg/kg Intravenous Dose in Healthy Adults

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

October 31, 2012

Study Completion Date

March 31, 2013

Conditions
MethemoglobinemiaCongenital Methemoglobinemia
Interventions
DRUG

Methylene Blue

Sponsors
All Listed Sponsors
lead

American Regent, Inc.

INDUSTRY